Suthar RR, Purandare N, Shah S, Agrawal A, Puranik A, Rangarajan V. FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma.
Clin Nucl Med 2023;
48:e332-e333. [PMID:
37075257 DOI:
10.1097/rlu.0000000000004661]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/21/2023]
Abstract
ABSTRACT
Fibrolamellar hepatocellular carcinoma (HCC) is a variant of HCC. It is a malignant tumor, but its imaging features often overlap focal nodular hyperplasia, which is a benign entity. FDG PET/CT is also not much help in these cases because both lesions do not concentrate FDG. We present one such case of fibrolamellar HCC with FAPI PET/CT positivity.
Collapse